Atlas FDA

Praxis Extended RAS Panel

FDA premarket approval P160038/S009 · decided 2019-03-05

Approval details

PMA number
P160038
Supplement
S009
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Praxis Extended RAS Panel
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Applicant
Illumina, Inc.
Date received
2019-02-15
Decision date
2019-03-05
Days to decision
18 days
Decision code
OK30
Product code
PQP
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
Remove redundant testing and to update a manufacturing process for a saturated solution.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MISEQDX UNIVERSAL KIT 1.0 (DEN130042)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY (K124006)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX PLATFORM (DEN130011)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY (K132750)Illumina, Inc.2013-11-19
ILLUMINA BEADXPRESS SYSTEM (K093128)Illumina, Inc.2010-04-28
ILLUMINA VERNCODE GENOTYPING TEST FOR FACOR V AND FACTOR II (K093129)Illumina, Inc.2010-04-28